Iomeron (Iomeprol)

Iomeprol works by delivering iodine atoms that strongly absorb X‑ray photons. When injected, the compound distributes within vascular and extracellular spaces, raising the radiodensity of those areas. This contrast difference is captured by imaging equipment, producing detailed pictures of anatomical structures until the agent is eliminated mainly by the kidneys.

The dose of Iomeron is individualized by the prescribing physician based on the type of imaging study, the patient’s body weight, renal function and the specific vascular or body compartment to be visualized. No standard dosing regimen is provided here; the healthcare professional sets the appropriate amount for each case.

Iomeron should only be used in pregnancy or while breastfeeding when the diagnostic benefit outweighs potential risks. Iodine crosses the placenta and can be secreted in breast milk, so clinicians must evaluate maternal and fetal considerations carefully and discuss alternatives when possible.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Iomeron is a non‑ionic, low‑osmolality iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. It provides comparable image quality while reducing the incidence of discomfort and adverse renal effects. Clinicians may choose it over ionic agents when a lower risk of hypersensitivity and nephrotoxicity is desired.

Iomeron should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the solution from direct sunlight, excessive heat and moisture. Do not freeze the product, and avoid shaking the vial to maintain solution integrity.

Iomeron is supplied as a sterile solution for injection and is administered by a qualified healthcare professional via intra‑arterial, intra‑articular or intrathecal routes, depending on the imaging study. The injection is performed under aseptic conditions, using appropriate catheters or needles, and the volume is determined by the prescribing clinician.

The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury especially in patients with pre‑existing renal impairment, and profound hypotension that may lead to cardiovascular instability. Prompt recognition and emergency management are essential if any of these events occur.

Iomeron is contraindicated in patients with a known hypersensitivity to iodinated contrast media, those with uncontrolled severe renal failure, and individuals with hyperthyroidism who are at risk of iodine‑induced thyroid storm. Caution is also advised for neonates, infants and patients with unstable cardiovascular status.